一个基于外基因组的特异性转录组签名,用于分析调节模式和修改瘤免疫微环境透在三阴性乳腺癌中的透
Han Wang1, Ruo Wang1, Lei Luo2,3
1Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Frontiers in immunology
|December 21, 2023
概括
这项研究开发了一个9基因风险评分模型,使用外体相关基因来预测三阴性乳腺癌 (TNBC) 的预后. 高风险的TNBC患者表现较差,这表明需要量身定制的治疗方法.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 免疫学 免疫学 免疫学
背景情况:
- 三阴性乳腺癌 (TNBC) 是具有侵略性和异质性的,缺乏有效的治疗方法.
- 外体在癌症的进展,转移和耐药性方面发挥着关键作用.
- 外体相关基因,TNBC异质性和瘤免疫微环境之间的联系需要进一步调查.
研究的目的:
- 识别与TNBC预后和免疫微环境相关的外体相关基因.
- 为TNBC患者构建一个预测风险评分模型.
- 探索外基因组衍生基因组信息对个性化治疗策略的潜力.
主要方法:
- 利用外体相关的基因组和机器学习算法 (例如,Cox提升) 来开发风险评分模型.
- 在多个数据集中验证了9基因模型,以评估其预后能力.
- 在高风险和低风险组之间分析了基因突变概况和药物敏感性.
主要成果:
- 一个9基因风险评分模型有效地将TNBC患者分为高风险和低风险组.
- 高风险组的预后较差,与免疫透和反应减少有关.
- 确定CLDN7作为一个具有显著预后价值的关键枢纽基因.
结论:
- 与外体相关的基因对TNBC风险分层有价值,识别需要积极治疗的患者.
- 对外体的基因组分析为个性化治疗决策和改善TNBC患者的治疗结果提供了潜力.
- 作为TNBC的预后生物标志物,CLDN7显示出前景.
更多相关视频
09:30Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes
Published on: May 24, 2019
7.4K
08:49Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
Published on: May 27, 2016
11.2K
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
